BOSCARO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 7.458
EU - Europa 3.588
AS - Asia 2.417
SA - Sud America 625
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
Totale 14.186
Nazione #
US - Stati Uniti d'America 7.398
SG - Singapore 952
UA - Ucraina 825
BR - Brasile 531
CN - Cina 422
DE - Germania 414
IE - Irlanda 398
RU - Federazione Russa 388
SE - Svezia 360
TR - Turchia 318
DK - Danimarca 316
IT - Italia 270
HK - Hong Kong 219
FI - Finlandia 190
VN - Vietnam 169
KR - Corea 168
GB - Regno Unito 167
FR - Francia 121
IN - India 46
CI - Costa d'Avorio 45
NL - Olanda 42
BE - Belgio 32
AR - Argentina 31
CA - Canada 27
EC - Ecuador 23
MX - Messico 23
BD - Bangladesh 18
PL - Polonia 18
ZA - Sudafrica 18
JP - Giappone 17
ID - Indonesia 16
UZ - Uzbekistan 12
CO - Colombia 11
ES - Italia 11
LT - Lituania 11
PK - Pakistan 9
IQ - Iraq 7
MA - Marocco 7
PY - Paraguay 7
AT - Austria 6
CL - Cile 6
EU - Europa 6
AE - Emirati Arabi Uniti 5
RO - Romania 5
UY - Uruguay 5
VE - Venezuela 5
AZ - Azerbaigian 4
NP - Nepal 4
PE - Perù 4
SA - Arabia Saudita 4
AU - Australia 3
EG - Egitto 3
IR - Iran 3
KE - Kenya 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HN - Honduras 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
PS - Palestinian Territory 2
RS - Serbia 2
TN - Tunisia 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DM - Dominica 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
LY - Libia 1
NI - Nicaragua 1
PT - Portogallo 1
QA - Qatar 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.186
Città #
Chandler 857
Jacksonville 831
Des Moines 706
Ashburn 617
Singapore 567
Boardman 448
Fairfield 423
Dublin 397
New York 268
Dallas 257
Wilmington 251
Woodbridge 230
Hong Kong 219
Seattle 183
Ann Arbor 179
Lawrence 168
Princeton 168
Houston 163
Cambridge 145
San Mateo 137
Hefei 102
Moscow 101
Los Angeles 94
Beijing 93
Centro 64
Ho Chi Minh City 62
San Diego 55
The Dalles 55
São Paulo 54
Abidjan 45
Hanoi 35
Munich 35
Buffalo 34
Brussels 32
Turin 31
Washington 26
Norwalk 23
Rio de Janeiro 21
Brooklyn 17
Warsaw 17
London 16
Civitanova Marche 15
Falls Church 15
Helsinki 15
Stockholm 15
Montreal 14
Tokyo 14
Guangzhou 13
Santa Clara 13
Shanghai 13
Ankara 11
Belo Horizonte 11
Chicago 11
Denver 11
Rome 11
Tashkent 11
Wuhan 11
Turku 10
Frankfurt am Main 9
Mexico City 9
Mumbai 9
Orem 9
Amsterdam 8
Curitiba 8
Guayaquil 8
Haiphong 8
Johannesburg 8
Nuremberg 8
Porto Alegre 8
Quito 8
Aracaju 7
Auburn Hills 7
Biên Hòa 7
Chennai 7
Council Bluffs 7
Poplar 7
Recife 7
San Francisco 7
Atlanta 6
Boston 6
Columbus 6
New Delhi 6
Phoenix 6
Redmond 6
Ribeirão Preto 6
Toronto 6
Yiwu 6
Jakarta 5
Manchester 5
Ottawa 5
Querétaro 5
Thái Bình 5
Ancona 4
Baghdad 4
Campinas 4
Cape Town 4
Contagem 4
Criciúma 4
Da Nang 4
Dhaka 4
Totale 8.707
Nome #
Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors. 158
Production of peroxynitrite by human spermatozoa and its possible role on sperm motility. 155
ISOLATION AND CHARACTERIZATION OF MESENCHYMAL CELLS FROM PITUITARY TUMOURS 149
Persistent psychological distress in patients treated for endocrine disease. 143
Prolactinomas,Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas 141
Adrenal incidentaloma: surgical update. 136
A new germline point mutation in Ret exon 8 (cys515ser) in a family with medullary thyroid carcinoma 133
Age-related changes in glucocorticoid fast feedback inhibition of adrenocorticotropin in man. 126
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. 124
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. 124
Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. 122
Aldosterone as a cardiovascular risk factor. 120
Development of overt Cushing's syndrome in patients with adrenal incidentaloma 120
Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. 119
Free thiols in human spermatozoa: involvement of Na/K-ATPase and Ca-ATPase activities in sperm motility. 117
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. 117
Diabetes mellitus-associated periodontitis: differences between type 1 and type 2 diabetes mellitus. 117
Adipose cell-adrenal interactions: current knowledge and future perspectives. 114
Protective effect of leg fat against cardiovascular risk factors in obese premenopausal women 113
Bone health and aldosterone excess 113
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome 113
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants. 113
Correlates of perceived health related quality of life in obese, overweight and normal weight older adults: an observational study 112
Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers 111
Adipose tissue 11 beta-hydrioxysteroid deydrogenase type 1 expression in obesity and Cushing's syndrome 109
Diagnosis of co-morbid axis-I psychiatric disorders among women with newly diagnosed, untreated endocrine disorders. 109
Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse. 108
Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. 107
Diagnosis and complications of Cushing's syndrome: a consensus statement 106
Multiple endocrine neoplasia type 1 and adrenal lesions 106
Development of overt Cushing's syndrome in patients with adrenal incidentaloma. 146 (1): 61-66,2002 105
Genetic mutations in thyroid carcinoma 104
GH secretagogues and hypothalamo-pituitary-adrenal axis 104
A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma. 104
Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists 104
Psychosocial impairment in patients treated for pituitary disease: a controlled study 103
Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas 103
Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment. 103
Cushing's syndrome 101
Coenzyme Q10 supplementation in infertile men with idiopathic asthenozoospermia: an open, uncontrolled pilot study. 101
Coenzyme Q10 and male infertility 100
Diagnosis and management of adrenal incidentalomas. 99
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. 99
Adrenocortical carcinoma:experience in 45 patients. 98
Personality characteristics and quality of life in patients treated for Cushing's syndrome 97
Chemical-physical properties of lipoproteins in anorexia nervosa. 96
Oleoylethanolamide protects human sperm cells from oxidation stress: studies on cases of idiopathic infertility 96
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. 95
Sexual symptoms in endocrine diseases: psychosomatic perspectives. 95
Adrenal incidentaloma: effects on bone metabolism. 95
Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis. 94
Association of somatotrophinomas with loss of alleles on chromosome 11 and with gps mutations . 94
Corticotropin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and Pseudo-Cushing state: a comparative study. 93
Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism. 93
Improvement of sperm cells motility after CoQ10 treatment in infertile males with idiopathic asthenozoospermia. 92
Obesity and body mass index (BMI) in ralation to the life style and psycho-social aspects. 91
Consideration in diagnosis of Cushing's syndrome 91
Self image and quality of life in acromegaly 91
ADRENAL MORPHO-FUNCTIONAL ALTERATIONS IN PATIENTS WITH ACROMEGALY. 91
Brief report: A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma 90
Adrenal incidentaloma. 90
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. 90
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion 90
Diagnosis of primary aldosteronism: from screening to subtype differentiation 89
Recovery of Bone Mineral Density after surgical cure, but not by ketoconazole treatment, in Cushing's syndrome 89
Left ventricular structure and functional characteristic in Cushing's syndrome 89
Obesity and body mass index (BMI) in relation to life-style and psycho-social aspects. 89
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome 89
Corticotropin-releasing effect of exarelin, a peptyl GH secretagogue in normal subjects pretreated with metyrapone or RU 486, a glucocorticoid receptor antagonist, and patients with Addison's disease 88
La nutraceutica nell’infertilità maschile. 88
Anaplastic Thyroid Carcinoma. 88
Effects of raloxifene on body fat distribution and lipid profile in healthy post menopausal women 87
Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation. 87
Fine-needle aspiration cytology of adrenal masses: a re-assessment with histological confirmation. 86
5 Management of primary aldosteronism: Its complications and their outcomes after treatment 86
High cardiovascular risk in patients with Cushing's syndrome accorìging to 1999 WHO/ISH guidelines 86
Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease 85
Effect of the serotonin antagonists ritanserin and ketanserin in Cushing disease 85
Molecolar analysis of CDKN1C and TP53 in sporadic adrenal tumors 85
Cortical adrenal mitochondrial morphology changes in functional state: new insights. 85
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. 85
New treatment guidelines on Cushing's disease. 83
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome 83
Effect of natural early menopause on bone mineral density. 82
Hormonal responses during various phrases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo. 82
Idiopathic infertility: susceptibility of spermatozoa to in vitro capacitation, in the presence and the absence of Palmitylethanolamide (an homologue of Anandamide), is strongly correlated with membrane polarity studied by Laurdan fluorescence. 82
Idiopathic infertility: effect of palmitoylethanolamide (a homologue of anandamide) on hyperactivated sperm cell motility and Ca2+ influx. 82
Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase. 82
Effect of glucocorticoids on adiponectin:a study in healthy subjects and Cushing's syndrome 82
Expanding role of AMPK in endocrinology 81
In situ analysis of human menin in normal and neoplastic pancreatic tissues: evidence for differential expression in exocrine and endocrine cells. 80
Chemotherapy at the end of life: an open question. 80
Endocrine aspects of cancer gene therapy. 80
Risk factors and long-term follw-up of adrenal incidentalomas. 80
Prevalence and natural history of adrenal incidentalomas. 80
Gene therapy for thyroid cancer. 80
A clinical index for rating severity in Cushing's syndrome 80
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 79
GH deficiency in the transitio period: body composition and gonad function. 79
Raloxifene and cadiovascular health: its relationschip to lipid and glucose metabolism, hemostatic and inflammation factors and cardiovascular function in postmenopausal women 78
Totale 9.948
Categoria #
all - tutte 67.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.053 0 0 0 0 0 79 223 93 228 115 231 84
2021/20221.131 50 239 9 64 19 93 39 74 82 135 83 244
2022/20232.866 202 221 173 211 217 897 0 183 594 10 114 44
2023/20241.387 254 40 72 233 229 303 18 49 0 32 9 148
2024/20252.093 134 207 123 21 86 57 137 78 567 129 218 336
2025/20262.252 364 429 214 583 560 102 0 0 0 0 0 0
Totale 14.275